Personalis, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Personalis, Inc. (PSNL) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.35% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-08-04
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2026-06-30 was 4.35%, a 4.57% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2026-03-31 was 3.97%, a 11.78% decline year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2025-09-30 was 4.16%, a 0.24% increase year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2025-06-30 was 4.16%, a 10.54% decline year-over-year.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.50%, a 3.23% decline from fiscal 2024.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.65%, a 0.21% decline from fiscal 2023.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.66%, a 10.17% increase from fiscal 2022.
- Personalis, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.23%, a 204.32% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.35% 10-Q · filed 2026-08-04 | 4.35% 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | 3.97% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 4.50% 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 4.16% 10-Q · filed 2025-11-04 | 4.50% 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | 4.16% 10-Q · filed 2026-08-04 | 4.50% 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | 4.50% 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 4.65% 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 4.15% 10-Q · filed 2025-11-04 | 4.65% 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | 4.65% 10-Q · filed 2025-08-05 | 4.65% 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | 4.33% 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 4.66% 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 4.43% 10-Q · filed 2024-11-06 | 4.43% 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 3.98% 10-Q · filed 2024-08-07 | 3.98% 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | 4.23% 10-K · filed 2024-02-28 | |||
| 2022-09-30 | 3.63% 10-Q · filed 2023-11-07 | 3.63% 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | 3.39% 10-Q · filed 2023-08-08 | 3.39% 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 2.13% 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | 1.39% 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 0.96% 10-Q · filed 2022-11-02 | 1.06% 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | 1.06% 10-Q · filed 2022-08-03 | 1.06% 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 1.06% 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | 1.66% 10-K · filed 2023-02-23 | |||
| 2020-09-30 | 0.39% 10-Q · filed 2021-11-04 | 1.66% 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | 0.44% 10-Q · filed 2021-08-04 | 1.66% 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | 1.66% 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | 2.52% 10-K · filed 2022-02-24 | |||
| 2019-09-30 | 1.73% 10-Q · filed 2020-11-05 | 2.52% 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 2.36% 10-Q · filed 2020-08-06 | 2.52% 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 2.52% 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 2.88% 10-K · filed 2021-02-25 | |||
| 2018-09-30 | 2.87% 10-Q · filed 2019-11-13 | 2.88% 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | 2.88% 10-Q · filed 2019-08-13 | 2.88% 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | 2.10% 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |